O-Linked &bgr;-N-Acetylglucosamine Transferase Directs Cell Proliferation in Idiopathic Pulmonary Arterial Hypertension
暂无分享,去创建一个
R. Dweik | S. Comhair | C. Farver | Liping Tian | K. Aulak | K. Asosingh | J. Barnes | G. Heresi
[1] R. Schermuly,et al. [Relevant issues in the pathology and pathobiology of pulmonary hypertension]. , 2014, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.
[2] A. Hsi,et al. Impact of insulin resistance on ventricular function in pulmonary arterial hypertension. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[3] E. Michelakis,et al. The Metabolic Theory of Pulmonary Arterial Hypertension , 2014, Circulation research.
[4] J. Loyd,et al. The Genetics of Pulmonary Arterial Hypertension , 2014, Circulation research.
[5] L. Wells,et al. Functional O-GlcNAc modifications: Implications in molecular regulation and pathophysiology , 2014, Critical reviews in biochemistry and molecular biology.
[6] 崇行 上垣内. Overexpression of O-GlcNAc by prostate cancer cells is significantly associated with poor prognosis of patients(前立腺癌細胞におけるO-GlcNAcの過剰発現は前立腺患者の予後不良と密接に関連している) , 2014 .
[7] R. Dweik,et al. Modification of Hyaluronan by Heavy Chains of Inter-α-Inhibitor in Idiopathic Pulmonary Arterial Hypertension* , 2014, The Journal of Biological Chemistry.
[8] M. Tammi,et al. Borate-aided anion exchange high-performance liquid chromatography of uridine diphosphate-sugars in brain, heart, adipose and liver tissues. , 2014, Journal of Chromatography A.
[9] H. Shimojo,et al. Overexpression of O-GlcNAc by prostate cancer cells is significantly associated with poor prognosis of patients , 2013, Prostate Cancer and Prostatic Disease.
[10] W. Herr,et al. HCF-1 Is Cleaved in the Active Site of O-GlcNAc Transferase , 2013, Science.
[11] Gerald W. Hart,et al. Diabetic Hyperglycemia activates CaMKII and Arrhythmias by O linked Glycosylation , 2013, Nature.
[12] D. Vocadlo,et al. Hyper-O-GlcNAcylation Is Anti-apoptotic and Maintains Constitutive NF-κB Activity in Pancreatic Cancer Cells* , 2013, The Journal of Biological Chemistry.
[13] J. Chatham,et al. Post-translational protein modification by O-linked N-acetyl-glucosamine: its role in mediating the adverse effects of diabetes on the heart. , 2013, Life sciences.
[14] James D. Thomas,et al. Fasting 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography to detect metabolic changes in pulmonary arterial hypertension hearts over 1 year. , 2013, Annals of the American Thoracic Society.
[15] H. Bøtker,et al. Impact of O-GlcNAc on cardioprotection by remote ischaemic preconditioning in non-diabetic and diabetic patients. , 2013, Cardiovascular research.
[16] D. Stewart,et al. Anticipated classes of new medications and molecular targets for pulmonary arterial hypertension , 2013, Pulmonary circulation.
[17] Horst Olschewski,et al. Updated clinical classification of pulmonary hypertension. , 2009, Journal of the American College of Cardiology.
[18] S. Erzurum,et al. Human primary lung endothelial cells in culture. , 2012, American journal of respiratory cell and molecular biology.
[19] Kevin W Eliceiri,et al. NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.
[20] N. Voelkel,et al. Pathobiology of pulmonary arterial hypertension and right ventricular failure , 2012, European Respiratory Journal.
[21] S. Archer,et al. Lung ¹⁸F-fluorodeoxyglucose positron emission tomography for diagnosis and monitoring of pulmonary arterial hypertension. , 2012, American journal of respiratory and critical care medicine.
[22] M. Reginato,et al. Critical Role of O-Linked β-N-Acetylglucosamine Transferase in Prostate Cancer Invasion, Angiogenesis, and Metastasis* , 2012, The Journal of Biological Chemistry.
[23] M. V. Vander Heiden,et al. Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. , 2011, Annual review of cell and developmental biology.
[24] T. Rice,et al. Unrecognized glucose intolerance is common in pulmonary arterial hypertension. , 2010, The Journal of Heart and Lung Transplantation.
[25] G. Hart,et al. Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease. , 2011, Annual review of biochemistry.
[26] M. Rigoulet,et al. The Warburg and Crabtree effects: On the origin of cancer cell energy metabolism and of yeast glucose repression. , 2011, Biochimica et biophysica acta.
[27] W. Herr,et al. O-GlcNAc Transferase Catalyzes Site-Specific Proteolysis of HCF-1 , 2011, Cell.
[28] H. Coller,et al. The hexosamine biosynthetic pathway couples growth factor-induced glutamine uptake to glucose metabolism. , 2010, Genes & development.
[29] T. Issad,et al. O-GlcNAc modification, insulin signaling and diabetic complications. , 2010, Diabetes & metabolism.
[30] G. Hart,et al. Increased Expression of β-N-Acetylglucosaminidase in Erythrocytes From Individuals With Pre-diabetes and Diabetes , 2010, Diabetes.
[31] J. Hanover,et al. The hexosamine signaling pathway: O-GlcNAc cycling in feast or famine. , 2010, Biochimica et biophysica acta.
[32] S. Archer,et al. A proposed mitochondrial-metabolic mechanism for initiation and maintenance of pulmonary arterial hypertension in fawn-hooded rats: the Warburg model of pulmonary arterial hypertension. , 2010, Advances in experimental medicine and biology.
[33] C. A. de la Motte,et al. Primary Murine Airway Smooth Muscle Cells Exposed to Poly(I,C) or Tunicamycin Synthesize a Leukocyte-adhesive Hyaluronan Matrix* , 2009, Journal of Biological Chemistry.
[34] G. Hansmann,et al. Insulin resistance in pulmonary arterial hypertension , 2008, European Respiratory Journal.
[35] Reid F. Thompson,et al. Enhanced activation of a “nutrient‐sensing” pathway with age contributes to insulin resistance , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[36] R. Dweik,et al. High levels of hyaluronan in idiopathic pulmonary arterial hypertension. , 2008, American journal of physiology. Lung cellular and molecular physiology.
[37] Jianxin Xie,et al. Hepatic Glucose Sensing via the CREB Coactivator CRTC2 , 2008, Science.
[38] E. Salido,et al. The GLUT-1 XbaI Gene Polymorphism Is Associated with Vascular Calcifications in Nondiabetic Uremic Patients , 2008, Nephron Clinical Practice.
[39] Winship Herr,et al. E2F activation of S phase promoters via association with HCF-1 and the MLL family of histone H3K4 methyltransferases. , 2007, Molecular cell.
[40] N. Taniguchi. A sugar-coated switch for cellular growth and arrest. , 2007, Nature chemical biology.
[41] Gerald W. Hart,et al. Cycling of O-linked β-N-acetylglucosamine on nucleocytoplasmic proteins , 2007, Nature.
[42] Ahmad Y. Sheikh,et al. Pulmonary Arterial Hypertension Is Linked to Insulin Resistance and Reversed by Peroxisome Proliferator–Activated Receptor-&ggr; Activation , 2007 .
[43] Raed A Dweik,et al. Alterations of cellular bioenergetics in pulmonary artery endothelial cells , 2007, Proceedings of the National Academy of Sciences.
[44] G. Hart,et al. Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins. , 2007, Nature.
[45] Ahmad Y. Sheikh,et al. Pulmonary arterial hypertension is linked to insulin resistance and reversed by peroxisome proliferator-activated receptor-gamma activation. , 2007, Circulation.
[46] M. Buse,et al. Identification of the Major Site of O-Linked β-N-Acetylglucosamine Modification in the C Terminus of Insulin Receptor Substrate-1 *S , 2006, Molecular & Cellular Proteomics.
[47] J. Hanover,et al. The Hexosamine Signaling Pathway: Deciphering the "O-GlcNAc Code" , 2005, Science's STKE.
[48] G. Hart,et al. Dynamic O-GlcNAc Modification of Nucleocytoplasmic Proteins in Response to Stress , 2004, Journal of Biological Chemistry.
[49] W. Herr,et al. Proteolytic processing is necessary to separate and ensure proper cell growth and cytokinesis functions of HCF‐1 , 2003, The EMBO journal.
[50] G. Hart,et al. A role for N-acetylglucosamine as a nutrient sensor and mediator of insulin resistance , 2003, Cellular and Molecular Life Sciences CMLS.
[51] G. Parker,et al. Altered glycan-dependent signaling induces insulin resistance and hyperleptinemia , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[52] G. Hart,et al. Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[53] G. Hart,et al. Dynamic O-Glycosylation of Nuclear and Cytosolic Proteins , 2002, The Journal of Biological Chemistry.
[54] G. Hart,et al. Dynamic O-Glycosylation of Nuclear and Cytosolic Proteins , 2001, The Journal of Biological Chemistry.
[55] Carolyn R. Bertozzi,et al. Essentials of Glycobiology , 1999 .
[56] J. Hanover,et al. O-Linked GlcNAc Transferase Is a Conserved Nucleocytoplasmic Protein Containing Tetratricopeptide Repeats* , 1997, The Journal of Biological Chemistry.
[57] G. Hart,et al. Dynamic Glycosylation of Nuclear and Cytosolic Proteins , 1997, The Journal of Biological Chemistry.
[58] G. Hart,et al. Glycosylation of the c-Myc transactivation domain. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[59] S. Marshall,et al. Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance. , 1991, The Journal of biological chemistry.
[60] O. Warburg. [Origin of cancer cells]. , 1956, Oncologia.